Clinical Trials Logo

Clinical Trial Summary

This pilot study hypothesizes that use of the Regenesis Provant Wound Therapy System (a radiofrequency device) twice daily over venous stasis ulcers (wounds thought to occur due to improper functioning of valves in the veins, usually of the legs) will result in increased rates of healing and a larger proportion of completely healed wounds after 12 weeks of therapy compared to wounds treated identically using a Provant device that is not activated to emit radiofrequency.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01050023
Study type Interventional
Source Southern California Institute for Research and Education
Contact
Status Active, not recruiting
Phase N/A
Start date November 2009
Completion date November 2011

See also
  Status Clinical Trial Phase
Completed NCT00425178 - FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers Phase 1
Terminated NCT03416049 - The Effects of Pulsed Elelectro-Magnetic Fields ("PEMF") in the Treatment of Venous Stasis Leg Ulcers
Completed NCT02009501 - V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds N/A
Withdrawn NCT01113658 - Clinical Evaluation of the SNaP Wound Care System N/A
Completed NCT00823446 - Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers Phase 1
Completed NCT01129986 - A Post Marketing Clinical Study Utilizing DermaStream and Saline in Venous Ulcers N/A
Completed NCT00832091 - Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers Phase 2
Completed NCT01754506 - Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers N/A
Completed NCT01567150 - Wound Fluid Protease Levels During Use of Novel Wound Dressing Phase 4
Completed NCT00852995 - Dose Finding Study of HP802-247 in Venous Leg Ulcers Phase 2
Completed NCT00720239 - Taliderm Dressing for Venous Ulcers Phase 0